Primary aldosteronism (PA) is one of the most common causes of secondary hypertension but remains largely unrecognized and untreated. The objective of this population-based cohort study was to understand the outcomes of a specialized clinic on rates of evaluation and treatment of PA in the context of secondary factors. Less than 1% of patients expected to have PA were ever formally diagnosed and treated. These findings suggest that a system-level approach to assist with investigation and treatment of PA may be highly effective in closing care gaps and improving clinical outcomes.
